caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1972940708

Kelly Lang-SheppardAPRN-CNS

Certified Clinical Nurse SpecialistOklahoma City, OKI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Kelly Lang-Sheppard's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ELKHATIB, FATEH4596
INTEGRIS SOUTH OKLAHOMA CITY HOSPITAL CORPORATION1529
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
798
Unique beneficiaries
—
Total services
1,520
Distinct HCPCS
10
Medicare payment
$63K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 101 Certified Clinical Nurse Specialist providers in OK — top quintile (cohort median 270).
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
52
By payment type
Food and Beverage$1K
PRESCRIBING · PART D · 2024
Total Rx claims
3,457
Beneficiaries
—
Total drug cost
$2.2M
Distinct drugs
37
Brand share
77.7%
Top prescribed drugs
Semaglutide492 claims
Tirzepatide343 claims
Levothyroxine Sodium163 claims
Insulin Degludec161 claims
Insulin Degludec144 claims